North Annette Insider Trades

Insider Trading History

Track insider trading activity for North Annette. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & General Counsel
Holding Value $4.42M 58,600 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.21M 58,600 shares
$37.68
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
EVP & General Counsel
Holding Value $883k 11,696 shares
Last Trade
Feb 09, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.3k 669 shares
$36.30
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $933k 12,365 shares
Last Trade
Aug 30, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$800k 10,000 shares
$80.00
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $10.9M 144,609 shares
Last Trade
Aug 30, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$772k 10,000 shares
$77.20
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $1.69M 22,365 shares
Last Trade
Aug 30, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$772k 10,000 shares
$77.20
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $2.07M 27,365 shares
Last Trade
Jun 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.17M 15,000 shares
$77.99
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $11.7M 154,609 shares
Last Trade
Jun 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.17M 15,000 shares
$77.99
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $1.64M 21,699 shares
Last Trade
Jun 15, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.16M 15,000 shares
$77.03
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $12.8M 169,609 shares
Last Trade
May 06, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$381k 5,882 shares
$64.78
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $933k 12,365 shares
Last Trade
May 06, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$381k 5,882 shares
$64.78
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $1.96M 25,983 shares
Last Trade
Mar 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.2M 20,000 shares
$109.80
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $13.2M 175,491 shares
Last Trade
Mar 08, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.14M 20,000 shares
$106.98
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $2M 26,483 shares
Last Trade
Mar 08, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.14M 20,000 shares
$106.98
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $2.2M 29,175 shares
Last Trade
Feb 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.08M 29,175 shares
$140.01
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $650k 8,616 shares
Last Trade
Feb 02, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.17M 9,016 shares
$129.88
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $14.8M 195,491 shares
Last Trade
Feb 02, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 9,016 shares
$131.56
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $681k 9,016 shares
Last Trade
Feb 02, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.19M 9,016 shares
$131.56
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $1.21M 15,984 shares
Last Trade
Feb 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.99M 15,984 shares
$124.46
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $1.08M 14,354 shares
Last Trade
Feb 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.98M 15,984 shares
$123.65
$75.49
Turning Point Therapeutics
Turning Point Therapeutics TPTX
Evp, General Counsel & Secty.
Holding Value $15.4M 204,507 shares
Last Trade
Feb 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.99M 15,984 shares
$124.46
$75.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up